CLOBETASOL PROPIONATE

CLOBETASOL PROPIONATE was reported 10734 times

These side effects are most commonly reported by patients taking CLOBETASOL PROPIONATE:

# Side effect Count
0 DRUG INEFFECTIVE 1121
1 PRURITUS 992
2 OFF LABEL USE 687
3 RASH 687
4 PSORIASIS 561
5 PRODUCT USE IN UNAPPROVED INDICATION 559
6 FATIGUE 536
7 HEADACHE 505
8 DIARRHOEA 453
9 NAUSEA 449
10 DRY SKIN 426
11 ARTHRALGIA 422
12 PAIN 410
13 SKIN EXFOLIATION 404
14 ERYTHEMA 345
15 CONDITION AGGRAVATED 340
16 INJECTION SITE PAIN 338
17 PRODUCT DOSE OMISSION ISSUE 326
18 DYSPNOEA 317
19 DERMATITIS ATOPIC 302
20 DIZZINESS 301
21 PAIN IN EXTREMITY 284
22 ECZEMA 282
23 FALL 263
24 VOMITING 240
25 PYREXIA 233
26 INSOMNIA 230
27 MALAISE 228
28 ASTHENIA 219
29 WEIGHT DECREASED 217
30 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 209
31 ANXIETY 206
32 COUGH 203
33 PNEUMONIA 198
34 DEPRESSION 197
35 BACK PAIN 196
36 ALOPECIA 194
37 SKIN FISSURES 188
38 PERIPHERAL SWELLING 177
39 PRODUCT USE ISSUE 171
40 URTICARIA 170
41 DECREASED APPETITE 154
42 URINARY TRACT INFECTION 154
43 COVID-19 147
44 HYPERSENSITIVITY 146
45 HYPERTENSION 146
46 MYALGIA 144
47 PSORIATIC ARTHROPATHY 144
48 NASOPHARYNGITIS 140
49 GAIT DISTURBANCE 138
50 MUSCLE SPASMS 137
51 FEELING ABNORMAL 136
52 WEIGHT INCREASED 135
53 BURNING SENSATION 131
54 DRUG HYPERSENSITIVITY 130
55 ABDOMINAL DISCOMFORT 126
56 DEATH 123
57 DRY EYE 122
58 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 119
59 CONSTIPATION 118
60 ILLNESS 118
61 NEUROPATHY PERIPHERAL 118
62 INFECTION 117
63 SINUSITIS 115
64 ABDOMINAL PAIN 114
65 CONTUSION 114
66 SKIN ATROPHY 113
67 SKIN HAEMORRHAGE 113
68 INCORRECT DOSE ADMINISTERED 112
69 CHEST PAIN 111
70 ABDOMINAL PAIN UPPER 110
71 SKIN DISCOLOURATION 110
72 VISION BLURRED 110
73 BLISTER 109
74 HYPOAESTHESIA 109
75 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 108
76 BLOOD PRESSURE INCREASED 104
77 RASH PRURITIC 104
78 INJECTION SITE ERYTHEMA 103
79 OEDEMA PERIPHERAL 103
80 ACCIDENTAL EXPOSURE TO PRODUCT 98
81 ANAEMIA 98
82 TREATMENT FAILURE 95
83 JOINT SWELLING 94
84 SKIN BURNING SENSATION 94
85 MUSCULAR WEAKNESS 93
86 SYNCOPE 93
87 INFLUENZA 92
88 INJECTION SITE SWELLING 92
89 PARAESTHESIA 92
90 MYOCARDIAL INFARCTION 91
91 UPPER RESPIRATORY TRACT INFECTION 91
92 EYE PAIN 90
93 SLEEP DISORDER 90
94 ACUTE KIDNEY INJURY 89
95 EYE PRURITUS 88
96 SKIN DISORDER 87
97 THERAPEUTIC RESPONSE DECREASED 87
98 HYPERHIDROSIS 86
99 STRESS 86
100 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 85
101 CELLULITIS 84
102 THERAPEUTIC RESPONSE SHORTENED 84
103 RASH ERYTHEMATOUS 83
104 DYSURIA 80
105 RASH MACULAR 79
106 RENAL FAILURE 78
107 HYPOTENSION 77
108 SOMNOLENCE 77
109 APPLICATION SITE PAIN 76
110 ARTHRITIS 76
111 DEHYDRATION 76
112 PRODUCT QUALITY ISSUE 76
113 MIGRAINE 74
114 OROPHARYNGEAL PAIN 73
115 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 73
116 PALPITATIONS 72
117 BRONCHITIS 71
118 DERMATITIS 71
119 INTENTIONAL PRODUCT MISUSE 71
120 OCULAR HYPERAEMIA 69
121 CHEST DISCOMFORT 68
122 DISEASE PROGRESSION 68
123 HOT FLUSH 68
124 ASTHMA 67
125 EYE IRRITATION 67
126 INFLUENZA LIKE ILLNESS 67
127 INJECTION SITE BRUISING 67
128 INJECTION SITE PRURITUS 67
129 SEPSIS 67
130 SKIN LESION 67
131 DIABETES MELLITUS 66
132 LACRIMATION INCREASED 66
133 MEMORY IMPAIRMENT 66
134 NASAL CONGESTION 66
135 VISUAL IMPAIRMENT 65
136 MOBILITY DECREASED 64
137 STOMATITIS 64
138 BLOOD GLUCOSE INCREASED 63
139 CONFUSIONAL STATE 63
140 GASTROOESOPHAGEAL REFLUX DISEASE 63
141 CATARACT 62
142 SWELLING 62
143 CEREBROVASCULAR ACCIDENT 61
144 HEPATIC ENZYME INCREASED 61
145 ACNE 60
146 RHINORRHOEA 59
147 CHRONIC KIDNEY DISEASE 58
148 HAEMOGLOBIN DECREASED 58
149 PULMONARY EMBOLISM 58
150 THERAPEUTIC PRODUCT EFFECT DECREASED 58
151 DYSPEPSIA 57
152 PAIN OF SKIN 57
153 SKIN SWELLING 57
154 STAPHYLOCOCCAL INFECTION 57
155 TREMOR 57
156 LYMPHADENOPATHY 56
157 SKIN WEEPING 56
158 FLUSHING 55
159 DRUG INTERACTION 54
160 DRY MOUTH 54
161 GASTROINTESTINAL DISORDER 54
162 NEUTROPENIA 54
163 PEMPHIGOID 54
164 ABDOMINAL DISTENSION 53
165 EYE SWELLING 53
166 CHILLS 52
167 EXPOSURE VIA SKIN CONTACT 52
168 FUNGAL INFECTION 52
169 BALANCE DISORDER 51
170 CUSHING^S SYNDROME 51
171 SKIN ULCER 51
172 CUSHING'S SYNDROME 50
173 INJECTION SITE REACTION 50
174 NECK PAIN 50
175 NO ADVERSE EVENT 50
176 PLATELET COUNT DECREASED 50
177 SKIN IRRITATION 50
178 WHITE BLOOD CELL COUNT DECREASED 50
179 DYSPHAGIA 49
180 OSTEOARTHRITIS 49
181 OVERDOSE 49
182 HAEMORRHAGE 48
183 HOSPITALISATION 48
184 SQUAMOUS CELL CARCINOMA OF SKIN 48
185 SWELLING FACE 48
186 BLOOD PRESSURE DECREASED 47
187 EPISTAXIS 47
188 FEELING HOT 47
189 GAIT INABILITY 47
190 INTENTIONAL PRODUCT USE ISSUE 47
191 LEUKOPENIA 47
192 MUSCULOSKELETAL STIFFNESS 47
193 PRODUCT DOSE OMISSION 47
194 RENAL DISORDER 47
195 POOR QUALITY SLEEP 46
196 TACHYCARDIA 46
197 ATRIAL FIBRILLATION 45
198 HERPES ZOSTER 45
199 ORAL HERPES 45
200 PRODUCT PHYSICAL CONSISTENCY ISSUE 45
201 EMOTIONAL DISTRESS 44
202 EXPIRED PRODUCT ADMINISTERED 44
203 DEVICE DELIVERY SYSTEM ISSUE 43
204 HEART RATE INCREASED 43
205 HYPOGLYCAEMIA 43
206 LOSS OF CONSCIOUSNESS 43
207 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 43
208 CUSHINGOID 42
209 DISCOMFORT 42
210 INCORRECT DRUG ADMINISTRATION DURATION 42
211 ADRENAL INSUFFICIENCY 41
212 DERMATITIS BULLOUS 41
213 DRUG DOSE OMISSION 41
214 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 41
215 SCRATCH 41
216 SURGERY 41
217 DERMATITIS CONTACT 40
218 FEBRILE NEUTROPENIA 40
219 INJECTION SITE HAEMORRHAGE 40
220 SCAB 40
221 UNEVALUABLE EVENT 40
222 OEDEMA 39
223 PANCYTOPENIA 39
224 PRODUCT DOSE OMISSION IN ERROR 39
225 RHEUMATOID ARTHRITIS 39
226 VERTIGO 39
227 ARTHROPATHY 38
228 HYPOACUSIS 38
229 PRODUCTIVE COUGH 38
230 THROMBOSIS 38
231 ANAPHYLACTIC REACTION 37
232 BONE PAIN 37
233 DEPRESSED MOOD 37
234 DEVICE ISSUE 37
235 INTENTIONAL DOSE OMISSION 37
236 PAPULE 37
237 PRODUCT CONTAINER ISSUE 37
238 THROMBOCYTOPENIA 37
239 WOUND 37
240 DEEP VEIN THROMBOSIS 36
241 INJECTION SITE RASH 36
242 OSTEOPOROSIS 36
243 RENAL IMPAIRMENT 36
244 SKIN INFECTION 36
245 THERAPY NON-RESPONDER 36
246 CARDIAC DISORDER 35
247 DRUG INTOLERANCE 35
248 HYPOKALAEMIA 35
249 MATERNAL EXPOSURE DURING PREGNANCY 35
250 POLLAKIURIA 35
251 SKIN PLAQUE 35
252 ADVERSE DRUG REACTION 34
253 CONJUNCTIVITIS 34
254 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 34
255 DYSPHONIA 34
256 GENERAL PHYSICAL HEALTH DETERIORATION 34
257 INFLAMMATION 34
258 NEPHROLITHIASIS 34
259 THERAPY INTERRUPTED 34
260 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 34
261 ALANINE AMINOTRANSFERASE INCREASED 33
262 APPLICATION SITE PRURITUS 33
263 HYPONATRAEMIA 33
264 NECROTISING FASCIITIS 33
265 WHEEZING 33
266 APPLICATION SITE ERYTHEMA 32
267 FLATULENCE 32
268 INFUSION RELATED REACTION 32
269 LETHARGY 32
270 NIGHT SWEATS 32
271 DECREASED INTEREST 31
272 HEART RATE DECREASED 31
273 LIMB DISCOMFORT 31
274 SEPTIC SHOCK 31
275 TINNITUS 31
276 ASPARTATE AMINOTRANSFERASE INCREASED 30
277 BLOOD CHOLESTEROL INCREASED 30
278 CARDIAC FAILURE CONGESTIVE 30
279 HALLUCINATION 30
280 INJECTION SITE MASS 30
281 ORAL CANDIDIASIS 30
282 SENSORY DISTURBANCE 30
283 TOPICAL STEROID WITHDRAWAL REACTION 30
284 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 29
285 DISTURBANCE IN ATTENTION 29
286 DRUG ERUPTION 29
287 EAR INFECTION 29
288 EXTRA DOSE ADMINISTERED 29
289 LIMB INJURY 29
290 OXYGEN SATURATION DECREASED 29
291 PLEURAL EFFUSION 29
292 RASH PAPULAR 29
293 SEASONAL ALLERGY 29
294 SUICIDAL IDEATION 29
295 THERAPEUTIC RESPONSE UNEXPECTED 29
296 BASAL CELL CARCINOMA 28
297 EYE DISORDER 28
298 FEELING COLD 28
299 NEURALGIA 28
300 PRODUCT STORAGE ERROR 28
301 ADVERSE EVENT 27
302 C-REACTIVE PROTEIN INCREASED 27
303 CROHN^S DISEASE 27
304 IMPAIRED HEALING 27
305 INJECTION SITE URTICARIA 27
306 NEOPLASM MALIGNANT 27
307 PULMONARY OEDEMA 27
308 SINUS DISORDER 27
309 THERAPY PARTIAL RESPONDER 27
310 TREATMENT NONCOMPLIANCE 27
311 TYPE 2 DIABETES MELLITUS 27
312 BLOOD POTASSIUM DECREASED 26
313 CARDIAC FAILURE 26
314 CEREBRAL DISORDER 26
315 DRUG EFFECT DECREASED 26
316 EOSINOPHILIA 26
317 HEAD INJURY 26
318 HIP ARTHROPLASTY 26
319 KNEE ARTHROPLASTY 26
320 ONYCHOCLASIS 26
321 RESPIRATORY TRACT INFECTION 26
322 SEIZURE 26
323 WHITE BLOOD CELL COUNT INCREASED 26
324 AMNESIA 25
325 COLITIS ULCERATIVE 25
326 GASTRITIS 25
327 INTERSTITIAL LUNG DISEASE 25
328 INTESTINAL OBSTRUCTION 25
329 JOINT STIFFNESS 25
330 LIP SWELLING 25
331 LOWER RESPIRATORY TRACT INFECTION 25
332 MOUTH ULCERATION 25
333 MUSCULOSKELETAL PAIN 25
334 PANCREATITIS 25
335 ROAD TRAFFIC ACCIDENT 25
336 SNEEZING 25
337 SQUAMOUS CELL CARCINOMA 25
338 DIVERTICULITIS 24
339 ECONOMIC PROBLEM 24
340 GASTROINTESTINAL HAEMORRHAGE 24
341 ILL-DEFINED DISORDER 24
342 INCORRECT PRODUCT ADMINISTRATION DURATION 24
343 INJURY 24
344 IRRITABILITY 24
345 ORAL PAIN 24
346 PERIPHERAL COLDNESS 24
347 RECTAL HAEMORRHAGE 24
348 ROSACEA 24
349 CONTRAINDICATED PRODUCT ADMINISTERED 23
350 DEVICE RELATED INFECTION 23
351 DISEASE RECURRENCE 23
352 DYSPNOEA EXERTIONAL 23
353 DYSSTASIA 23
354 EYE DISCHARGE 23
355 FOLLICULITIS 23
356 GLAUCOMA 23
357 LICHEN PLANUS 23
358 NERVE COMPRESSION 23
359 STREPTOCOCCAL INFECTION 23
360 SWOLLEN TONGUE 23
361 TENDERNESS 23
362 THROAT IRRITATION 23
363 TOXICITY TO VARIOUS AGENTS 23
364 VIRAL INFECTION 23
365 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 22
366 DYSGEUSIA 22
367 HYPERGLYCAEMIA 22
368 INCORRECT DOSAGE ADMINISTERED 22
369 MALIGNANT NEOPLASM PROGRESSION 22
370 MUSCULOSKELETAL DISCOMFORT 22
371 NEOPLASM SKIN 22
372 NERVOUSNESS 22
373 NEURODERMATITIS 22
374 PHOTOSENSITIVITY REACTION 22
375 PRODUCT PRESCRIBING ERROR 22
376 PRODUCT SUBSTITUTION ISSUE 22
377 RESPIRATORY FAILURE 22
378 RESTLESSNESS 22
379 SKIN CANCER 22
380 SLEEP APNOEA SYNDROME 22
381 CARDIAC ARREST 21
382 CHOLELITHIASIS 21
383 DERMATITIS ALLERGIC 21
384 KAPOSI^S SARCOMA 21
385 LUNG DISORDER 21
386 MUSCULOSKELETAL CHEST PAIN 21
387 NIGHTMARE 21
388 PNEUMONITIS 21
389 RADICULOPATHY 21
390 RASH PUSTULAR 21
391 TOOTH DISORDER 21
392 URINARY TRACT DISORDER 21
393 VAGINAL HAEMORRHAGE 21
394 BRAIN FOG 20
395 DISORIENTATION 20
396 DRUG-INDUCED LIVER INJURY 20
397 GLUCOSE TOLERANCE IMPAIRED 20
398 HAEMATOCHEZIA 20
399 HAEMATOCRIT DECREASED 20
400 HEPATIC FAILURE 20
401 HEPATIC FUNCTION ABNORMAL 20
402 JOINT RANGE OF MOTION DECREASED 20
403 OSTEOPENIA 20
404 PAIN IN JAW 20
405 RASH MACULO-PAPULAR 20
406 RETCHING 20
407 RIB FRACTURE 20
408 SCIATICA 20
409 SKIN LACERATION 20
410 ABORTION SPONTANEOUS 19
411 BLOOD GLUCOSE DECREASED 19
412 BLOOD SODIUM DECREASED 19
413 CORONARY ARTERY DISEASE 19
414 CYSTITIS 19
415 HEPATIC STEATOSIS 19
416 HYPERKERATOSIS 19
417 OSTEONECROSIS 19
418 POOR QUALITY PRODUCT ADMINISTERED 19
419 SCAR 19
420 SKIN STRIAE 19
421 SPEECH DISORDER 19
422 TOOTH ABSCESS 19
423 UPPER LIMB FRACTURE 19
424 URINARY INCONTINENCE 19
425 ANHEDONIA 18
426 BACK DISORDER 18
427 BLOOD ALKALINE PHOSPHATASE INCREASED 18
428 BREAST CANCER 18
429 CANDIDA INFECTION 18
430 COLITIS 18
431 DEAFNESS 18
432 DEVICE MALFUNCTION 18
433 FLUID RETENTION 18
434 FOOT FRACTURE 18
435 GLYCOSYLATED HAEMOGLOBIN INCREASED 18
436 HAEMATEMESIS 18
437 HAEMOPTYSIS 18
438 HYPOXIA 18
439 INITIAL INSOMNIA 18
440 INSURANCE ISSUE 18
441 LICHEN SCLEROSUS 18
442 LIVER DISORDER 18
443 LOCALISED INFECTION 18
444 MIDDLE INSOMNIA 18
445 MULTIPLE ALLERGIES 18
446 NEOPLASM PROGRESSION 18
447 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 18
448 SEBORRHOEIC KERATOSIS 18
449 SINUS CONGESTION 18
450 SKIN MASS 18
451 TRANSIENT ISCHAEMIC ATTACK 18
452 ULCER 18
453 ACUTE MYOCARDIAL INFARCTION 17
454 CLOSTRIDIUM DIFFICILE INFECTION 17
455 HAEMORRHOIDS 17
456 HYPERLIPIDAEMIA 17
457 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 17
458 IMMUNODEFICIENCY 17
459 INFUSION SITE ERYTHEMA 17
460 INFUSION SITE PAIN 17
461 INJECTION SITE DISCOLOURATION 17
462 MALIGNANT MELANOMA 17
463 MOVEMENT DISORDER 17
464 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17
465 PANIC ATTACK 17
466 PNEUMONIA BACTERIAL 17
467 PRODUCT PRESCRIBING ISSUE 17
468 PULMONARY MASS 17
469 PUSTULAR PSORIASIS 17
470 RASH GENERALISED 17
471 REBOUND EFFECT 17
472 RESPIRATORY DISORDER 17
473 RESPIRATORY TRACT CONGESTION 17
474 SKIN HYPERTROPHY 17
475 SKIN WARM 17
476 TENOSYNOVITIS 17
477 THERAPY CESSATION 17
478 URINARY RETENTION 17
479 ANGINA PECTORIS 16
480 BREAST CANCER FEMALE 16
481 CARPAL TUNNEL SYNDROME 16
482 CONVULSION 16
483 CRYING 16
484 DIPLOPIA 16
485 DRUG ADMINISTRATION ERROR 16
486 DRUG EFFECT INCOMPLETE 16
487 DRUG EFFECT LESS THAN EXPECTED 16
488 DRUG WITHDRAWAL SYNDROME 16
489 EATING DISORDER 16
490 EMOTIONAL DISORDER 16
491 ERECTILE DYSFUNCTION 16
492 HAEMATOMA 16
493 HAIR COLOUR CHANGES 16
494 HYPERSOMNIA 16
495 HYPOTHYROIDISM 16
496 INTERVERTEBRAL DISC PROTRUSION 16
497 LIVER FUNCTION TEST INCREASED 16
498 LYMPHOPENIA 16
499 MELANOCYTIC NAEVUS 16
500 MENTAL DISORDER 16
501 MENTAL STATUS CHANGES 16
502 PELVIC PAIN 16
503 PIGMENTATION DISORDER 16
504 POST PROCEDURAL COMPLICATION 16
505 PRODUCT USE COMPLAINT 16
506 RENAL FAILURE ACUTE 16
507 THROAT TIGHTNESS 16
508 VITAMIN D DEFICIENCY 16
509 ABNORMAL DREAMS 15
510 AGEUSIA 15
511 CHROMATURIA 15
512 COAGULOPATHY 15
513 COGNITIVE DISORDER 15
514 CYTOMEGALOVIRUS INFECTION 15
515 DEPRESSED LEVEL OF CONSCIOUSNESS 15
516 DRUG PRESCRIBING ERROR 15
517 EXPOSURE DURING PREGNANCY 15
518 FEEDING DISORDER 15
519 FREQUENT BOWEL MOVEMENTS 15
520 GASTRIC DISORDER 15
521 HIP FRACTURE 15
522 INFLAMMATORY BOWEL DISEASE 15
523 IRRITABLE BOWEL SYNDROME 15
524 LIVER FUNCTION TEST ABNORMAL 15
525 MACULAR DEGENERATION 15
526 MACULE 15
527 MOOD SWINGS 15
528 MULTIPLE SCLEROSIS 15
529 NEUTROPHIL COUNT DECREASED 15
530 NODULE 15
531 OCULAR DISCOMFORT 15
532 PLASMA CELL MYELOMA 15
533 PRODUCT DISPENSING ERROR 15
534 PSEUDOMONAS INFECTION 15
535 RENAL INJURY 15
536 ROTATOR CUFF SYNDROME 15
537 SKIN REACTION 15
538 TASTE DISORDER 15
539 ADRENAL SUPPRESSION 14
540 APPLICATION SITE IRRITATION 14
541 ARRHYTHMIA 14
542 BILIARY SEPSIS 14
543 BLOOD TRIGLYCERIDES INCREASED 14
544 BRADYCARDIA 14
545 DEVICE DEFECTIVE 14
546 DRUG DOSE OMISSION BY DEVICE 14
547 EYE INFECTION 14
548 EYE INFLAMMATION 14
549 FEELING JITTERY 14
550 HAIR TEXTURE ABNORMAL 14
551 HEART RATE IRREGULAR 14
552 HYPERKALAEMIA 14
553 HYPOPHAGIA 14
554 IMMUNE SYSTEM DISORDER 14
555 IMPAIRED GASTRIC EMPTYING 14
556 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14
557 INJECTION SITE IRRITATION 14
558 MASS 14
559 MEDICATION ERROR 14
560 PANCREATITIS ACUTE 14
561 PROCEDURAL PAIN 14
562 PULMONARY HYPERTENSION 14
563 PYELONEPHRITIS 14
564 SECONDARY ADRENOCORTICAL INSUFFICIENCY 14
565 SPINAL FRACTURE 14
566 STEROID WITHDRAWAL SYNDROME 14
567 THIRST 14
568 TOXIC EPIDERMAL NECROLYSIS 14
569 TRANSAMINASES INCREASED 14
570 VULVOVAGINAL BURNING SENSATION 14
571 WITHDRAWAL SYNDROME 14
572 APPLICATION SITE RASH 13
573 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 13
574 BLINDNESS 13
575 BLOOD CORTISOL DECREASED 13
576 BLOOD CREATININE INCREASED 13
577 COVID-19 PNEUMONIA 13
578 DERMATITIS ACNEIFORM 13
579 DRY THROAT 13
580 DYSARTHRIA 13
581 DYSKINESIA 13
582 EAR DISCOMFORT 13
583 EAR PAIN 13
584 FEELING OF BODY TEMPERATURE CHANGE 13
585 FIBROMYALGIA 13
586 HEAD DISCOMFORT 13
587 HERPES SIMPLEX 13
588 IMPAIRED QUALITY OF LIFE 13
589 LIGAMENT SPRAIN 13
590 LOW DENSITY LIPOPROTEIN INCREASED 13
591 LUNG NEOPLASM MALIGNANT 13
592 MITRAL VALVE INCOMPETENCE 13
593 MUSCLE TIGHTNESS 13
594 NAIL DISORDER 13
595 PARAESTHESIA ORAL 13
596 PERICARDIAL EFFUSION 13
597 PHARYNGITIS 13
598 PRESYNCOPE 13
599 PRODUCT ADMINISTRATION ERROR 13
600 PRODUCT DISTRIBUTION ISSUE 13
601 PROSTATE CANCER 13
602 PRURITUS GENERALISED 13
603 PUSTULE 13
604 REBOUND ATOPIC DERMATITIS 13
605 RED BLOOD CELL COUNT DECREASED 13
606 RESTLESS LEGS SYNDROME 13
607 SEBORRHOEIC DERMATITIS 13
608 STEROID DIABETES 13
609 SYSTEMIC LUPUS ERYTHEMATOSUS 13
610 AGRANULOCYTOSIS 12
611 ANGIOEDEMA 12
612 ARTERIOSCLEROSIS 12
613 ASCITES 12
614 BACTERIAL INFECTION 12
615 BLOOD TEST ABNORMAL 12
616 DERMATITIS EXFOLIATIVE GENERALISED 12
617 ENTEROCOCCAL INFECTION 12
618 ENTHESOPATHY 12
619 FOOD ALLERGY 12
620 FOOT DEFORMITY 12
621 GALLBLADDER DISORDER 12
622 GASTROENTERITIS VIRAL 12
623 GLOSSODYNIA 12
624 GOUT 12
625 HERNIA 12
626 HIDRADENITIS 12
627 HYPERCHOLESTEROLAEMIA 12
628 INJECTION SITE DISCOMFORT 12
629 JOINT EFFUSION 12
630 LACERATION 12
631 LUMBAR SPINAL STENOSIS 12
632 MUSCULOSKELETAL DISORDER 12
633 NOCTURIA 12
634 OBESITY 12
635 PARANASAL SINUS DISCOMFORT 12
636 PRODUCT AVAILABILITY ISSUE 12
637 PRODUCT LEAKAGE 12
638 PULMONARY FIBROSIS 12
639 RHINITIS ALLERGIC 12
640 SJOGREN^S SYNDROME 12
641 SKIN EROSION 12
642 SKIN HYPERPIGMENTATION 12
643 TOOTH INFECTION 12
644 TOOTHACHE 12
645 TUBULOINTERSTITIAL NEPHRITIS 12
646 UNRESPONSIVE TO STIMULI 12
647 ABDOMINAL PAIN LOWER 11
648 ABSCESS 11
649 ANGER 11
650 ARTHROPOD BITE 11
651 BACTERAEMIA 11
652 BLEPHARITIS 11
653 BLOOD BLISTER 11
654 BLOOD LACTATE DEHYDROGENASE INCREASED 11
655 BLOOD POTASSIUM INCREASED 11
656 BLOOD PRESSURE ABNORMAL 11
657 BLOOD UREA INCREASED 11
658 BURSITIS 11
659 CLOSTRIDIUM DIFFICILE COLITIS 11
660 DELIRIUM 11
661 ECCHYMOSIS 11
662 EXOSTOSIS 11
663 EYE ALLERGY 11
664 EYELID MARGIN CRUSTING 11
665 FULL BLOOD COUNT DECREASED 11
666 GASTROENTERITIS 11
667 INFUSION SITE DISCHARGE 11
668 INJECTION SITE VESICLES 11
669 INJECTION SITE WARMTH 11
670 JOINT INJURY 11
671 LYMPHOEDEMA 11
672 MENTAL IMPAIRMENT 11
673 MULTIPLE SCLEROSIS RELAPSE 11
674 NEUTROPENIC SEPSIS 11
675 ORAL MUCOSAL BLISTERING 11
676 PARONYCHIA 11
677 PERIORBITAL SWELLING 11
678 PHARYNGITIS STREPTOCOCCAL 11
679 PLATELET COUNT INCREASED 11
680 POLYARTHRITIS 11
681 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 11
682 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11
683 PYODERMA GANGRENOSUM 11
684 SENSITIVE SKIN 11
685 SENSITIVITY TO WEATHER CHANGE 11
686 SINUS TACHYCARDIA 11
687 SKIN ABRASION 11
688 SKIN TIGHTNESS 11
689 SNORING 11
690 SPINAL PAIN 11
691 STAPHYLOCOCCAL BACTERAEMIA 11
692 SUNBURN 11
693 THYROID MASS 11
694 TRIGGER FINGER 11
695 UNDERDOSE 11
696 VISUAL ACUITY REDUCED 11
697 WEIGHT FLUCTUATION 11
698 WRONG TECHNIQUE IN DRUG USAGE PROCESS 11
699 XEROSIS 11
700 ACUTE RESPIRATORY FAILURE 10
701 AGITATION 10
702 APPLICATION SITE VESICLES 10
703 BEDRIDDEN 10
704 BLADDER DISORDER 10
705 BLOOD BILIRUBIN INCREASED 10
706 BLOOD MAGNESIUM DECREASED 10
707 BUNDLE BRANCH BLOCK RIGHT 10
708 CARDIAC MURMUR 10
709 CEREBRAL HAEMORRHAGE 10
710 CEREBRAL INFARCTION 10
711 COLD SWEAT 10
712 COMPLICATION ASSOCIATED WITH DEVICE 10
713 CUTANEOUS LUPUS ERYTHEMATOSUS 10
714 DENTAL CARIES 10
715 DERMATITIS PSORIASIFORM 10
716 DEVICE DISLOCATION 10
717 DIABETES MELLITUS INADEQUATE CONTROL 10
718 DUODENAL ULCER 10
719 ELECTROLYTE IMBALANCE 10
720 END STAGE RENAL DISEASE 10
721 ENTEROCOLITIS 10
722 ERYTHRODERMIC PSORIASIS 10
723 ESSENTIAL HYPERTENSION 10
724 EYELID PAIN 10
725 FEAR 10
726 FOREIGN BODY SENSATION IN EYES 10
727 FURUNCLE 10
728 GINGIVAL PAIN 10
729 HAIR DISORDER 10
730 HEPATIC CIRRHOSIS 10
731 HEPATOTOXICITY 10
732 HUMAN HERPESVIRUS 8 INFECTION 10
733 HYPOTONIA 10
734 INCREASED APPETITE 10
735 INFUSION SITE SWELLING 10
736 INJECTION SITE HAEMATOMA 10
737 INJECTION SITE INDURATION 10
738 INTERVERTEBRAL DISC DEGENERATION 10
739 KIDNEY INFECTION 10
740 LICHENOID KERATOSIS 10
741 LIQUID PRODUCT PHYSICAL ISSUE 10
742 METASTASES TO BONE 10
743 MICTURITION URGENCY 10
744 MOOD ALTERED 10
745 MULTIPLE INJURIES 10
746 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10
747 MUSCLE STRAIN 10
748 NEEDLE ISSUE 10
749 NEUTROPHIL COUNT INCREASED 10
750 ONYCHOMYCOSIS 10
751 PEMPHIGUS 10
752 POST PROCEDURAL INFECTION 10
753 PRODUCT FORMULATION ISSUE 10
754 PRODUCT PACKAGING ISSUE 10
755 PRODUCT PHYSICAL ISSUE 10
756 PSEUDO CUSHING^S SYNDROME 10
757 SKIN WOUND 10
758 SPINAL OSTEOARTHRITIS 10
759 SUDDEN DEATH 10
760 TEMPERATURE INTOLERANCE 10
761 TOXIC SKIN ERUPTION 10
762 TRICUSPID VALVE INCOMPETENCE 10
763 UPPER-AIRWAY COUGH SYNDROME 10
764 VASODILATATION 10
765 ABASIA 9
766 ACARODERMATITIS 9
767 ACCIDENTAL OVERDOSE 9
768 ACINETOBACTER INFECTION 9
769 ACTINIC KERATOSIS 9
770 ALOPECIA SCARRING 9
771 ANKLE FRACTURE 9
772 ANKYLOSING SPONDYLITIS 9
773 APHASIA 9
774 APHTHOUS ULCER 9
775 APPLICATION SITE DRYNESS 9
776 BIPOLAR DISORDER 9
777 BLINDNESS UNILATERAL 9
778 BLOOD CALCIUM DECREASED 9
779 BLOOD PRESSURE FLUCTUATION 9
780 BOWEL MOVEMENT IRREGULARITY 9
781 CENTRAL OBESITY 9
782 CENTRAL SEROUS CHORIORETINOPATHY 9
783 CHOLANGITIS 9
784 CHOLECYSTECTOMY 9
785 COMPRESSION FRACTURE 9
786 CROHN'S DISEASE 9
787 CUTANEOUS VASCULITIS 9
788 CYST 9
789 CYTOKINE RELEASE SYNDROME 9
790 CYTOMEGALOVIRUS INFECTION REACTIVATION 9
791 DEMENTIA 9
792 DEVICE BREAKAGE 9
793 DISABILITY 9
794 DRUG ABUSE 9
795 DRUG DISPENSING ERROR 9
796 DYSLIPIDAEMIA 9
797 ERYTHEMA MULTIFORME 9
798 EXFOLIATIVE RASH 9
799 EYE HAEMORRHAGE 9
800 FLANK PAIN 9
801 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9
802 GASTROINTESTINAL INFECTION 9
803 GRAFT VERSUS HOST DISEASE 9
804 GREATER TROCHANTERIC PAIN SYNDROME 9
805 HAEMATURIA 9
806 HAIR GROWTH ABNORMAL 9
807 HORDEOLUM 9
808 HOSPICE CARE 9
809 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 9
810 HYPERTRICHOSIS 9
811 INCONTINENCE 9
812 JOINT NOISE 9
813 LARGE INTESTINE POLYP 9
814 LARYNGITIS 9
815 LEFT VENTRICULAR HYPERTROPHY 9
816 LOCAL SWELLING 9
817 LYMPHOCYTE COUNT DECREASED 9
818 MELAENA 9
819 MUSCLE TWITCHING 9
820 MYOSITIS 9
821 NERVOUS SYSTEM DISORDER 9
822 ORAL DISCOMFORT 9
823 OROPHARYNGEAL DISCOMFORT 9
824 PARKINSON^S DISEASE 9
825 PHOTOPHOBIA 9
826 PLANTAR FASCIITIS 9
827 PNEUMOTHORAX 9
828 PRESCRIBED UNDERDOSE 9
829 PRODUCT ADMINISTRATION INTERRUPTED 9
830 PRODUCT PREPARATION ERROR 9
831 RENAL CYST 9
832 RESPIRATORY DISTRESS 9
833 SARS-COV-2 TEST POSITIVE 9
834 SINUS BRADYCARDIA 9
835 SKIN HYPOPIGMENTATION 9
836 SPINAL OPERATION 9
837 SYMPTOM RECURRENCE 9
838 TOOTH FRACTURE 9
839 TOOTH LOSS 9
840 TUBERCULOSIS 9
841 VARICOSE VEIN 9
842 VITAMIN D DECREASED 9
843 ACTIVITIES OF DAILY LIVING IMPAIRED 8
844 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 8
845 AKATHISIA 8
846 APPLICATION SITE DISCOLOURATION 8
847 ATELECTASIS 8
848 BLOOD CORTICOTROPHIN DECREASED 8
849 BLOOD IRON DECREASED 8
850 BODY HEIGHT DECREASED 8
851 BRONCHIOLITIS OBLITERANS SYNDROME 8
852 BRONCHOPULMONARY ASPERGILLOSIS 8
853 CARDIO-RESPIRATORY ARREST 8
854 CHEMICAL BURN 8
855 DANDRUFF 8
856 DEVICE DIFFICULT TO USE 8
857 DEVICE OCCLUSION 8
858 DIARRHOEA HAEMORRHAGIC 8
859 DRUG RESISTANCE 8
860 EJECTION FRACTION DECREASED 8
861 ERYTHEMA OF EYELID 8
862 ESCHERICHIA INFECTION 8
863 EYELID SKIN DRYNESS 8
864 FACE OEDEMA 8
865 FEAR OF INJECTION 8
866 FUNGAL SKIN INFECTION 8
867 GASTROINTESTINAL PAIN 8
868 GRIP STRENGTH DECREASED 8
869 HEMIPARESIS 8
870 HEPATITIS 8
871 HUNGER 8
872 HYPERURICAEMIA 8
873 IMMUNOSUPPRESSION 8
874 INCORRECT ROUTE OF DRUG ADMINISTRATION 8
875 INCREASED TENDENCY TO BRUISE 8
876 INJECTION SITE EXTRAVASATION 8
877 IRON DEFICIENCY ANAEMIA 8
878 LABORATORY TEST ABNORMAL 8
879 LACK OF INJECTION SITE ROTATION 8
880 LENTIGO 8
881 LEUKOCYTOSIS 8
882 LOWER GASTROINTESTINAL HAEMORRHAGE 8
883 LOWER LIMB FRACTURE 8
884 MAJOR DEPRESSION 8
885 MUSCLE SPASTICITY 8
886 OESOPHAGITIS 8
887 ONYCHOLYSIS 8
888 ORTHOSTATIC HYPOTENSION 8
889 OSTEOMYELITIS 8
890 OSTEOSCLEROSIS 8
891 PANCREATITIS CHRONIC 8
892 PROTEINURIA 8
893 PULMONARY CONGESTION 8
894 PULMONARY HAEMORRHAGE 8
895 PURPURA 8
896 RASH VESICULAR 8
897 RESPIRATION ABNORMAL 8
898 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8
899 RHINITIS 8
900 SECRETION DISCHARGE 8
901 SEXUAL DYSFUNCTION 8
902 SKIN INDURATION 8
903 SPINAL DISORDER 8
904 STEVENS-JOHNSON SYNDROME 8
905 TERMINAL ILEITIS 8
906 UPPER GASTROINTESTINAL HAEMORRHAGE 8
907 UVEITIS 8
908 VASCULITIS 8
909 VISUAL FIELD DEFECT 8
910 VULVOVAGINAL DRYNESS 8
911 ADRENOCORTICAL INSUFFICIENCY ACUTE 7
912 ALOPECIA AREATA 7
913 ANGINA UNSTABLE 7
914 BLOOD GLUCOSE ABNORMAL 7
915 BODY TEMPERATURE INCREASED 7
916 BONE DENSITY DECREASED 7
917 BONE DISORDER 7
918 BRONCHIAL DISORDER 7
919 CARDIOMEGALY 7
920 CHEILITIS 7
921 CHOLESTASIS 7
922 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7
923 CORONARY ARTERY OCCLUSION 7
924 CYTOPENIA 7
925 DERMATITIS EXFOLIATIVE 7
926 DIABETIC KETOACIDOSIS 7
927 DIVERTICULUM INTESTINAL 7
928 DRUG DEPENDENCE 7
929 EMPHYSEMA 7
930 EPILEPSY 7
931 ERYSIPELAS 7
932 FAILURE TO THRIVE 7
933 FEELING DRUNK 7
934 GENERALISED OEDEMA 7
935 HAND FRACTURE 7
936 HEREDITARY ANGIOEDEMA 7
937 HYPERTENSIVE CRISIS 7
938 HYPERVOLAEMIA 7
939 IMPETIGO 7
940 INFUSION SITE EXTRAVASATION 7
941 INFUSION SITE HAEMORRHAGE 7
942 INFUSION SITE PRURITUS 7
943 INTERNATIONAL NORMALISED RATIO INCREASED 7
944 INTRAOCULAR PRESSURE INCREASED 7
945 JAUNDICE 7
946 LIBIDO DECREASED 7
947 LYMPHOMA 7
948 MATERNAL EXPOSURE BEFORE PREGNANCY 7
949 MATERNAL EXPOSURE DURING BREAST FEEDING 7
950 MOUTH SWELLING 7
951 MUCOSAL INFLAMMATION 7
952 MULTI-ORGAN FAILURE 7
953 NASAL DRYNESS 7
954 NEOPLASM 7
955 NEPHROGENIC ANAEMIA 7
956 NERVE INJURY 7
957 NO THERAPEUTIC RESPONSE 7
958 OVARIAN CYST 7
959 PNEUMONIA ASPIRATION 7
960 POOR VENOUS ACCESS 7
961 POST-TRAUMATIC STRESS DISORDER 7
962 POSTOPERATIVE WOUND INFECTION 7
963 PRE-EXISTING CONDITION IMPROVED 7
964 PREMATURE BABY 7
965 PROSTATIC SPECIFIC ANTIGEN INCREASED 7
966 PSYCHOTIC DISORDER 7
967 REBOUND ECZEMA 7
968 RHABDOMYOLYSIS 7
969 SELF-MEDICATION 7
970 SINUS HEADACHE 7
971 SKIN BACTERIAL INFECTION 7
972 SKIN CANDIDA 7
973 SKIN PAPILLOMA 7
974 SLEEP TERROR 7
975 SUSPECTED COVID-19 7
976 SWELLING OF EYELID 7
977 SYRINGE ISSUE 7
978 THERAPEUTIC PRODUCT INEFFECTIVE 7
979 TONSILLITIS 7
980 TOOTH EXTRACTION 7
981 TRICHORRHEXIS 7
982 VEIN DISORDER 7
983 VITAMIN B12 DEFICIENCY 7
984 VITILIGO 7
985 VULVOVAGINAL PRURITUS 7
986 WOUND COMPLICATION 7
987 WRIST FRACTURE 7
988 ACCIDENT 6
989 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6
990 ADVERSE REACTION 6
991 AGGRESSION 6
992 AMENORRHOEA 6
993 ANGIOPLASTY 6
994 ANTINUCLEAR ANTIBODY POSITIVE 6
995 AORTIC VALVE INCOMPETENCE 6
996 APHONIA 6
997 APPLICATION SITE EXFOLIATION 6
998 APPLICATION SITE INFLAMMATION 6
999 ARTERIOSCLEROSIS CORONARY ARTERY 6